A carregar...
Multiple myeloma: the (r)evolution of current therapy and a glance into the future
Over the past 20 years, the regulatory approval of several novel agents to treat multiple myeloma (MM) has prolonged median patient survival from 3 to 8-10 years. Increased understanding of MM biology has led to advances in diagnosis, prognosis, and response assessment, and has informed the developm...
Na minha lista:
| Publicado no: | Haematologica |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Fondazione Ferrata Storti
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556665/ https://ncbi.nlm.nih.gov/pubmed/33054076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.247015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|